1. Home
  2. KZIA vs MYSE Comparison

KZIA vs MYSE Comparison

Compare KZIA & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • MYSE
  • Stock Information
  • Founded
  • KZIA 1994
  • MYSE 2014
  • Country
  • KZIA Australia
  • MYSE United States
  • Employees
  • KZIA N/A
  • MYSE N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • MYSE Telecommunications Equipment
  • Sector
  • KZIA Health Care
  • MYSE Telecommunications
  • Exchange
  • KZIA Nasdaq
  • MYSE Nasdaq
  • Market Cap
  • KZIA 11.7M
  • MYSE 11.8M
  • IPO Year
  • KZIA 1999
  • MYSE 2021
  • Fundamental
  • Price
  • KZIA $7.56
  • MYSE $2.11
  • Analyst Decision
  • KZIA Strong Buy
  • MYSE
  • Analyst Count
  • KZIA 3
  • MYSE 0
  • Target Price
  • KZIA $16.00
  • MYSE N/A
  • AVG Volume (30 Days)
  • KZIA 72.8K
  • MYSE 96.0K
  • Earning Date
  • KZIA 12-26-2025
  • MYSE 11-13-2025
  • Dividend Yield
  • KZIA N/A
  • MYSE N/A
  • EPS Growth
  • KZIA N/A
  • MYSE N/A
  • EPS
  • KZIA N/A
  • MYSE N/A
  • Revenue
  • KZIA $1,246,312.00
  • MYSE $315.00
  • Revenue This Year
  • KZIA N/A
  • MYSE N/A
  • Revenue Next Year
  • KZIA N/A
  • MYSE N/A
  • P/E Ratio
  • KZIA N/A
  • MYSE N/A
  • Revenue Growth
  • KZIA N/A
  • MYSE N/A
  • 52 Week Low
  • KZIA $2.86
  • MYSE $1.61
  • 52 Week High
  • KZIA $34.40
  • MYSE $9.34
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 54.09
  • MYSE 36.40
  • Support Level
  • KZIA $7.18
  • MYSE $2.09
  • Resistance Level
  • KZIA $7.99
  • MYSE $2.33
  • Average True Range (ATR)
  • KZIA 0.46
  • MYSE 0.23
  • MACD
  • KZIA 0.03
  • MYSE -0.08
  • Stochastic Oscillator
  • KZIA 72.19
  • MYSE 4.19

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About MYSE Myseum Inc. Common Stock

Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

Share on Social Networks: